breast imaging use of tomo in kwh e fung
DESCRIPTION
TRANSCRIPT
Use of Breast Tomosynthesis Experience in
Kwong Wah Hospital
Dr Fung Po Yan Eliza
Specialist in Radiology
Associate Consultant, Well Women Clinic, Honorary Associate Consultant, Department of Radiology
Kwong Wah Hospital
Disclosure
• Neither I nor my immediate family members have a financial relaAonship with a commercial organizaAon that may have a direct or indirect interest in the content.
Tung Wah Group of Hospitals Breast Screening Service
Workflow of Screening mammography
Screening Mammogram
( Double Reading )
Abnormal ( Cat 3 or above )
Refer MulDdisciplinary
MeeDng
Early Follow up ( Phone
consultaDon )
Normal /benign ( Cat 1 and 2 )
Follow up in 2 years
( ConDnuous care )
AHendance of Screening Mammogram
0
2000
4000
6000
8000
10000
12000
14000
16000
18000
20000
1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011
Attendence
1993-‐3163 MMG 2000-‐10283 MMG 2011-‐18781 MMG
Tomosynthesis AccquisiAon
Hologic
Dense Breasts
Digital Breast Tomosynthesis FFDM Tomo
• Tube head moves in a continuous motion 15°(± 7.5°)
around the breast
• A total of 15 low-dose projection images are acquired at 1 projection/degree
• Tomo scan in 4 seconds
• Combo mode ( 3D + 2D ) in 13 secs
• Reconstruction images are displayed in 1mm slices at 90µm resolution
Hologic-‐Dimensions
Digital Breast Tomosynthesis
PotenAal Benefits of DBT • MicrocalcificaAons: -‐ DM slightly more sensiDve in detecDon ( Spangler ML : AJR 2011; 196(2):320-‐4 ) -‐ DBT equal or greater clarity ( Kopans D : Breast J 2011; 17:638 )
• Non-‐calcified lesions evaluaAon: -‐ Superior cancer visibility and conspicuity ( Andersson I : Eur Radiol 2008; 18: 2817 ) -‐ DBT superior to DM (Margarita L : Radiology Jan 2013 , 266, 89-‐95 )
PotenAal Benefits of DBT
• Specificity/Reduce recall rate: -‐ Increased when used adjuncDvely with DM ( Elizabetha A. Radfferty : Radiology 2013 : Volume 266: 104-‐11 ) ( Michell MJ : Clinical Radiology 2012 ; 67:976-‐981 ) ( TM Svahn : BJR 85, 2012 e1074-‐1082 ) (Ciabto S : Lancet Oncol 2013 Jun; 14(7):583-‐9) ( Hass BM : Radiology 2013 Jul 30 Epub )
Oslo Tomosynthesis Screening Trial
• ProspecDve Study • Nov 2010-‐Dec 2011 • Oslo University , 8 radiologists • Independent Double Reading with consensus • 12621 screening MMG • 50-‐69 year old • Screen biennially
Radiology: Volume 267: Number 1—April 2013
Oslo Tomosynthesis Screening Trial
Screening DM(2D)+DBT(3D)
DM Independent double reading
Arm A DM
Single reading
Arm B DM + CAD
Single reading
DM+DBT Independent double reading
Arm C DM + DBT
Single Reading
Arm D SyntheDc DM + DBT
Single reading
Methods
• 5 point raDng system (1=normal/benign, 2-‐5=>posiDve )
• For all cases >2 in at least one arm => ArbitraDon meeDng
• Published data in Arm A ( DM ) and Arm C ( DM + DBT )
• Among 12621 cases, 121 malignancy found
Outcome ( Rates per 1000 ) 2D vs Combo ( 2D + 3D )
DetecDon Rate * 6.1 8.0 +27
False PosiDve Rate* ( before arbitraDon )
61.1 53.1 -‐15
PosiDve PredicDve Value ( ajer arbitraDon )
29.1% 28.5% -‐2
Time*
45s
91s
+100
2D %
*Significant p=< 0.001
2D+3D
Outcome ( Rates per 1000 ) 2D vs Combo ( 2D + 3D )
DetecDon Rate *
6.1 8.0 +27
False PosiDve Rate* ( before arbitraDon )
61.1 53.1 -‐15
PosiDve PredicDve Value ( ajer arbitraDon )
29.1% 28.5% -‐2
Time*
45s
91s
+100
2D %
*Significant p=< 0.001
2D+3D
Outcome ( Rates per 1000 ) 2D vs Combo ( 2D + 3D )
DetecDon Rate * 6.1 8.0 +27
False PosiDve Rate* ( before arbitraDon )
61.1 53.1 -‐15
PosiDve PredicDve Value ( ajer arbitraDon )
29.1% 28.5% -‐2
Time*
45s
91s
+100
2D %
*Significant p=< 0.001
2D+3D
Breast Density
2D 2D+3D Difference
Faby 4 6 2
Scabered 26 36 10
Heterogenous Extreme
23 3
34 5
11 2
Invasive Cancer ( no of Ca ) 2D vs Combo ( 2D + 3D )
2D 2D+3D Difference
Total number Invasive Cancer
77 56
101 81
+24 +25
Grade I <15mm
17 37
32 59
+15 +22
LN negaDve 44 63 +19
Invasive Cancer ( no of Ca ) Tumour Grade
2D 2D+3D Difference
Total number Invasive Cancer
77 56
101 81
+24 +25
Grade I Grade II
17 29
32 35
+15 +6
Grade III 9 13 +4
Invasive Cancer ( no of Ca ) Lesion Size
2D 2D+3D Difference
<10mm 11-‐15mm
27 37
36 59
+9 +22
16-‐19mm >20mm
6 12
5 15
-‐1 3
Invasive Cancer ( no of Ca ) Lymph nodes status
2D 2D+3D Difference
LN negaDve LN posiDve Unknown
44 9 3
63 13 5
+19 4 2
Invasive Cancer ( no of Ca ) Radiological finding
2D 2D+3D Difference
Circumscribed mass
7
9
+2
Spiculated mass
28
37
+9
Architectural distorDon
8
16
+8
Asymmetric density
4
4
+0
CalcificaDons Mass with calcificaDons
6 3
6 9
+0 +6
In situ Cancers ( DCIS ) 2D vs Combo ( 2D + 3D )
2D 2D+3D Difference
Total number 21 20 -‐1
CalcificaDons 20 19 -‐1
Mass+calcificaDons
1 1 0
Oslo Tomosynthesis Screening Trial
• Significant increase in cancer detecDon rates
• ParDcularly useful for invasive cancers • Simultaneous decrease in false posiDve rates
Experience of Kwong Wah Hospital • Hologic Dimensions installaDon in Oct 2011
• Study Period : February to May 2012 • Call back for compression view ( CC or MLO view ) => Tomosynthesis
• Not used for calcificaDon workups • No preselecDon of paDents • 261 sets performed
• Compression Pressure • RadiaDon dose • Reason for call back ( Focal asymmetry/Mass/ Architectural distorDon/Others )
• Radiologists grade the Tomo vs FFDM (Superior/Equal/Inferior)
• Need to call back if Tomo is available
Experience of Kwong Wah Hospital
Results • Reduce recall rate by 61.3% • Especially useful in evaluaDng-‐focal asymmetry • Superior ( 64% ), Equal ( 34 % ) , Inferior ( 2% ) • Comparable breast compression ( 111% ) • Slight increased entrance radiaDon dose ( 129% )
• PaDent ( lible to no difference ) • Physician ( posiDve ) • Radiographer ( fast adopDon ) • Radiologist ( learning curve, extra-‐Dme , performance affected by the network , dedicated mammo viewer, memory space)
• Two-‐ views DM vs DBT ( 100MB vs 250 MB )
Experience of Kwong Wah Hospital
Asymmetric Density
Asymmetric Density
Asymmetric Density
Asymmetric Density
Asymmetric Density
Fibroadenoma
Fibroadenoma
Fibroadenoma
Invasive Carcinoma
Invasive Carcinoma
Invasive Carcinoma
Invasive Carcinoma
USG
Invasive Carcinoma
USG
Invasive Carcinoma
Tubular Carcinoma
Tubular Carcinoma
Tubular Carcinoma
DCIS
DCIS
DCIS
• Yung Mui Hing Video
Invasive Ductal Carcinoma
Invasive Ductal Carcinoma
Invasive Ductal Carcinoma
SyntheDc mammogram
• Generates from the Tomo data • No addiDonal radiaDon dose • Emulates 2D image:
– Facilitates comparison to old films
• Maintains important details from tomosynthesis slices – Interpreted in combinaDon with tomosynthesis images
Dose reduction in digital breast tomosynthesis (DBT) screeningusing synthetically reconstructed projection images: anobserver performance study
David Gur, ScD1, Margarita L. Zuley, MD2, Maria I. Anello, DO2, Grace Y. Rathfon, MD2,Denise M. Chough, M.D.2, Marie A. Ganott, M.D.2, Christiane M. Hakim, M.D.2, LuisaWallace, MD2, Amy Lu, MD2, and Andriy I. Bandos, PhD3
1University of Pittsburgh, Department of Radiology, Radiology Imaging Research, 3362 FifthAvenue, Pittsburgh, PA 152132Department of Radiology, Magee-Womens Hospital, 300 Halket Street, Pittsburgh, PA 152133University of Pittsburgh, Graduate School of Public Health, Department of Biostatistics, 130DeSoto Street, Pittsburgh, PA 15261
AbstractRationale and Objectives—Retrospectively compare interpretive performance of syntheticallyreconstructed two-dimensional images in combination with DBT versus FFDM plus DBT.
Materials and Methods—Ten radiologists trained in reading tomosynthesis examinationsinterpreted retrospectively, under two modes, 114 mammograms. One mode included the directlyacquired FFDM combined with DBT and the other, synthetically reconstructed projection imagescombined with DBT. The reconstructed images do not require additional radiation exposure. Wecompared the two modes with respect to “sensitivity”, namely recommendation to recall a breastwith either a pathology proven cancer (n=48) or a high risk lesion (n=6); and “specificity”, namelyno recommendation to recall a breast not depicting an abnormality (n=144) or depicting onlybenign abnormalities (n=30).
Results—The average sensitivity for FFDM with DBT was 0.826 versus 0.772 for syntheticFFDM with DBT (difference=0.054, p=0.017 and p=0.053 for fixed and random reader effect,respectively). The fraction of breasts with no, or benign, abnormalities recommended to berecalled were virtually the same: 0.298 and 0.297 for the two modalities, respectively (95%confidence intervals for the difference CI= −0.028, 0.036 and CI = −0.070, 0.066 for fixed andrandom reader effects, correspondingly). Sixteen additional clusters of micro-calcifications(“positive” breasts) were missed by all readers combined when interpreting the mode withsynthesized images versus FFDM.
Conclusion—Lower sensitivity with comparable specificity was observed with the testedversion of synthetically generated images versus FFDM, both combined with DBT. Improvedsynthesized images with experimentally verified acceptable diagnostic quality will be needed toeliminate double exposure during DBT based screening.
© 2011 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.Correspondence: David Gur, ScD, University of Pittsburgh, Department of Radiology, Radiology Imaging Research, 3362 FifthAvenue, Pittsburgh, PA 15213, Phone: 412-641-2513, Fax: 412-641-2582, [email protected]'s Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to ourcustomers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review ofthe resulting proof before it is published in its final citable form. Please note that during the production process errors may bediscovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
NIH Public AccessAuthor ManuscriptAcad Radiol. Author manuscript; available in PMC 2013 February 1.
Published in final edited form as:Acad Radiol. 2012 February ; 19(2): 166–171. doi:10.1016/j.acra.2011.10.003.
NIH
-PA Author Manuscript
NIH
-PA Author Manuscript
NIH
-PA Author Manuscript
114 MMG SyntheDc view+DBT vs DM+DBT Lower sensiDvity Comparable specificity Missed clustered microcal
Image Comparison DM Tomo Slice SyntheDc
Details are maintained DM SyntheDc Tomo Slice
Conspicuity of CalcificaDons SyntheDc DM Tomo Slice
SyntheDc FDDM
Future DirecDon
• In place of the convenDonal FDDM • FDA Approval ( May 2013 ) • Less radiaDon and paDent discomfort • DiagnosDc Quality ? • Oslo Tomosynthesis Screening Trial • DM+CAD vs SyntheDc view+DBT • RSNA 2013 ?
email : [email protected]
Thank you
Acknowledgment
• Department of Radiology, KWH • Dr Chun Ying LUI • Dr Kimmy KWOK • Dr William WONG • Dr Julian FONG • Dr Kevin LAU • Ms Daisy SIU • Mammography Team, KWH • Breast Centre, KWH • Dr Miranda CHAN • Dr Marcus YING • Dr Yolanda CHAN • Well Women Clinic • Dr Tung Yeung LEUNG • Dr Rebecca CHUNG • Dr Wai Ka HUNG • Dr Hang Yi So • Dr Hiu Wing Hong • Pathology Department • Dr Kong Ling MAK
The End